| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $46.8M | $2.0M | $145.1K |
| YoY Revenue Growth % | +2224.2% | +1288.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$86.9M | -$138.5M | -$26.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$101.4M | -$173.5M | -$30.7M |
| EBITDA (Normalized) | -$86.8M | -$138.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$63.1M | -$22.4M | -$13.0M |
| Capital Expenditures (CapEx) | $90.2K | $8.3K | — |
| Free Cash Flow (FCF) | -$63.2M | -$22.4M | -$13.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -36.9% | -45.0% | — |
| Cash & Short-Term Equivalents | $111.1M | $9.7M | — |
| Total Debt (Short + Long Term) | $50.1M | — | — |
| Total Stockholders' Equity | $246.8M | -$41.3M | — |